Trial Profile
Double-blind, placebo-controlled, 3-way crossover study to investigate the effect of 7-days repeat once daily inhaled doses of GW870086X [GSK-870086] administered via Diskhaler on airway responsiveness to AMP [adenosine monophosphate] in mild steroid-naive male asthmatics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 870086 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 01 Aug 2007 New trial record.